Barry Pearson is an experienced professional in the biopharmaceutical industry, currently serving as Director of Data Science at Amgen since August 2004. With a robust background in various roles including Sr. Principal Scientist and Senior Scientist, Barry has led teams within Drug Product Technologies to advance digital technologies and enhance efficiency in drug development. Notable achievements include leading the technology transfer for Amgen's product Xgeva and overseeing the successful manufacturing process for the Phase 2 drug AMG 745. Prior to Amgen, Barry worked at Regeneron Pharmaceuticals, contributing to the development of marketable formulations, and at Sulzer Biologics, providing critical analytical support in process development. Barry holds a Master of Science in Neuroscience from the University of Colorado Anschutz Medical Campus and a Bachelor of Arts in Neuroscience from Colgate University.
This person is not in any teams
This person is not in any offices